Recent Advances and Challenges in the Treatment of Major Depressive Disorder (Advances in Experimental Medicine and Biology)

個数:

Recent Advances and Challenges in the Treatment of Major Depressive Disorder (Advances in Experimental Medicine and Biology)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 436 p.
  • 言語 ENG
  • 商品コード 9789819744015

Full Description

This book reviews all aspects of major depressive disorder (MDD), casting light on its neurobiological underpinnings and describing the most recent advances in management. The book is divided into four sections, the first of which discusses MDD from a network science perspective, highlighting the alterations in functional and structural connectivity and presenting insights achieved through resting state functional MRI and the development of neuroimaging-based biomarkers. The second section examines important diagnostic and neurobiological issues, while the third considers the currently available specific treatments for MDD, including biofeedback, neurofeedback, cognitive behavioral therapy, acceptance and commitment therapy, neuromodulation therapy, psychodynamic therapy, and complementary and alternative medicine. A concluding section is devoted to promising emerging treatments, from novel psychopharmacological therapies through to virtual reality treatment, immunotherapy, biomarker-guided tailored therapy, and more. Written by leading experts from across the world, the book will be an excellent source of information for both researchers and practitioners.

Contents

Part I. Molecular Biology-based Treatment for Depression.- Chapter 1.  Neuroendocrinological Treatment Targets for Depressive Disorder.- Chapter 2. Psychophamacological Approaches for Neural Plasticity and Neurogenesis in Major Depressive Disorder.- Chapter 3. Efficacy, Safety and Tolerability of Psychedelics in Treatment Resistant Depression (TRD).- Chapter 4. Probiotics and Fecal Microbiota Transplantation in Major Depression: Doxa or Episteme?.- Chapter 5. Induced Pluripotent Stem Cells (iPSC) Technology for Major Depression.- Chapter 6. Combining Complementary and Alternative Medicine (CAM) with Conventional Treatments for Major Depressive Disorder.- Part II. Brain Network-based Treatments for Depression.- Chapter 7.  Application of Transcranial Direct and Alternating Current Stimulation (tDCS & tACS) on Major Depressive Disorder.- Chapter 8.  Repetitive Transcranial Magnetic Stimulation (rTMS) in Major Depression.- Chapter 9. Deep Brain Stimulation (DBS) in Treatment-resistant Depression (TRD): Hope and Concern.- Chapter 10. Electroconvulsive Therapy (ECT) in Major Depression: Oldie but Goodie.- Part III. Psychological Intervention based Treatments for Depression.- Chapter 11. Cognitive Behavioral Therapy and Mindfulness-based Cognitive Therapy for Depressive Disorders: Enhancing Access and Tailoring Interventions in Diverse Settings.- Chapter 12. Acceptance and Commitment Therapy for Major Depressive Disorder: Navigating Depression Treatment in Traditional and Digital Settings with Insights from Current Research.- Chapter 13.  The Importance of Psychotherapy for Treatment Resistant Depression.- Chapter 14. Personalized Well-Being Therapy (WBT) for Major Depression.- Part IV. Digital Psychiatry based Treatments for Depression.- Chapter 15. The Potential and Challenges of Virtual Reality as an Adjunctive Treatment of Depression Patients.- Chapter 16. The New Emerging Treatment Choice for Major Depressive Disorders: Digital Therapeutics.- Chapter 17. Telepsychiatry in the Treatment of Major Depressive Disorders.- Part V. Personalized Precision Treatments for Depression.- Chapter 18. Precision Medicine in Depression: The Role of Proteomics and Metabolomics in Personalized Treatment Approaches.- Chapter 19. Biomarker Guided Tailored Therapy in Major Depression.- Chapter 20.  Navigating the Intersection of Technology and Depression Precision Medicine.

最近チェックした商品